NEW YORK - The United States ratcheted up its safeguards against Ebola on Tuesday, requiring travelers from three countries at the center of an epidemic in West Africa to fly into one of five major airports conducting enhanced screening for the virus.
LONDON - Johnson & Johnson is accelerating work on its experimental Ebola vaccine and aims to produce 1 million doses next year, 250,000 of which are expected to be available by May.
PARIS - French biotech firm DBV Technologies - developer of what it says is a breakthrough treatment for peanut allergy sufferers - makes its U.S. market debut on Wednesday, with a Nasdaq listing set to raise funds for further research.
BOSTON - The U.S. Department of Homeland Security is investigating about two dozen cases of suspected cybersecurity flaws in medical devices and hospital equipment that officials fear could be exploited by hackers, a senior official at the agency told Reuters.
WASHINGTON - President Barack Obama and his senior advisers will meet on Wednesday with Ron Klain, the new Ebola "czar" charged with coordinating the U.S. response to the Ebola outbreak in West Africa that has ravaged three countries and alarmed Americans.
NEW YORK - The medical status of nurse Nina Pham, who contracted Ebola when she helped treat the first patient to be diagnosed with the disease on U.S. soil, was upgraded to good from fair on Tuesday, the National Institutes of Health (NIH) announced.
WASHINGTON - Nearly three-fourths of Americans support a ban on civilian air travel in and out of the West African countries that have experienced an Ebola outbreak, a new Reuters/Ipsos poll shows, suggesting growing pressure on President Barack Obama over the issue.
- Canadian drugmaker Tekmira Pharmaceuticals Corp has begun limited manufacturing of a therapeutic targeting the Ebola-Guinea virus.
- A lawyer for a Montana woman on Tuesday urged jurors in a U.S. court to find Johnson & Johnson's DePuy Orthopedics unit liable for failing to warn patients that metal-on-metal Pinnacle hip implants were defective at the close of the first trial over the device.
NEW YORK (Reuters Health) - Long after the Food and Drug Administration (FDA) issued recalls for dietary supplements tainted with banned drugs, more than half of the tainted supplements were still available for purchase, a new study found.